Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
This grant funds innovative research to boost minority health and health equity, focusing on diversity in clinical trials, equitable data, and understanding patient perspectives.
Funder: Food and Drug Administration (FDA)
Due Dates: No specified due date (Forecasted opportunity)
Funding Amounts: $1,000,000 total award; cooperative agreement funding
Summary: Funds innovative research to advance minority health and health equity, focusing on diversity in clinical trials, equitable data, and understanding diverse patient perspectives.
Key Information: Clinical trials are not allowed under this funding opportunity.
Description
This funding opportunity from the Food and Drug Administration (FDA) aims to support innovative research projects that strengthen and advance minority health and health equity objectives. The focus is on addressing disparities by promoting equity in clinical trials and data collection, as well as amplifying diverse patient voices.
Key areas of interest include:
- Advancing equity in clinical trials by supporting efforts to increase diversity among trial participants.
- Enhancing equitable data efforts by increasing the availability and quality of data on diverse populations, including ethnicity, race, age, disability status, and geographic location.
- Improving understanding of diverse patient perspectives, preferences, and unmet needs to ensure equity of voices in health research.
This opportunity is a cooperative agreement with a fixed award amount of $1,000,000. Importantly, clinical trials are not allowed under this funding mechanism.
